Abstract:ABSTRACT RUNX2 is a transcription factor critical for chondrocyte maturation and normal endochondral bone formation. It promotes the expression of factors catabolic to the cartilage extracellular matrix and is shown to be upregulated in human osteoarthritic cartilage and in murine articular cartilage following joint injury. To date, in vivo studies of RUNX2 overexpression in cartilage have been limited to forced expression in osteochondroprogenitor cells preventing investigation into the effects of chondrocyte-specific RUNX2 overexpression during development or in postnatal articular cartilage. Here, we used the Rosa26 Runx2 allele in combination with the inducible Col2a1 CreERT2 transgene or the inducible Acan CreERT2 knock-in allele to achieve chondrocyte-specific RUNX2 overexpression (OE) during embryonic development or in the postnatal articular cartilage of adult mice, respectively. RUNX2 OE was induced at E13.5 for all developmental studies and resulted in a phenotype resembling chondrodysplasia at E18.5. Histology and in situ hybridization analyses suggest an early onset of chondrocyte hypertrophy and accelerated terminal maturation in the limbs of the RUNX2 OE embryos compared to control embryos. Additionally, RUNX2 OE resulted in enhanced TUNEL staining indicative of increased chondrocyte apoptosis throughout all regions of the growth plate. For all postnatal studies, RUNX2 OE was induced at 2 months of age. Surprisingly, no histopathological signs of OA or cartilage catabolism were observed even six months following induction of RUNX2 OE in postnatal animals. Using the meniscal/ligamentous injury (MLI), a surgical model of knee joint destabilization and meniscal injury, however, we found that chondrocyte-specific RUNX2 OE accelerates the progression of OA pathogenesis following joint trauma. Histomorphometry and OARSI scoring confirmed decreased cartilage area two months following injury in the RUNX2 OE joints compared to control joints. Further, the numbers of MMP13-positive and TUNEL-positive chondrocytes were significantly greater in the articular cartilage of the RUNX2 OE joints compared to control joints one month following injury. Collectively, our data support that RUNX2 OE in growth plate chondrocytes is sufficient to promote their hypertrophy and terminal maturation during development. While RUNX2 overexpression alone is surprisingly insufficient to induce catabolic changes to the postnatal articular cartilage, it can accelerate the progression of post-traumatic OA. These results suggest that although increased RUNX2 expression may predetermine the rate of OA onset and/or progression following traumatic joint injury, alone this change is not sufficient to initiate the OA degenerative process.

Deletion of Runx2 in Articular Chondrocytes Decelerates the Progression of DMM-Induced Osteoarthritis in Adult Mice

Chondrocyte‐Specific RUNX2 Overexpression Accelerates Post‐traumatic Osteoarthritis Progression in Adult Mice

Runx2 and Runx3 differentially regulate articular chondrocytes during surgically induced osteoarthritis development

Chondrocyte-specific RUNX2 Overexpression Causes Chondrodysplasia During Development, but is Not Sufficient to Induce OA-like Articular Cartilage Degeneration in Adult Mice Without Injury

Delay in Articular Cartilage Degeneration of the Knee Joint by the Conditional Removal of Discoidin Domain Receptor 2 in a Spontaneous Mouse Model of Osteoarthritis

Deletion Of Runx2 In Condylar Chondrocytes Disrupts Tmj Tissue Homeostasis

Runx1 is a key regulator of articular cartilage homeostasis by orchestrating YAP, TGFβ, and Wnt signaling in articular cartilage formation and osteoarthritis

Mir‑204‑5p Inhibits the Occurrence and Development of Osteoarthritis by Targeting Runx2.

Inflammatory Microenvironment Promotes Extracellular Matrix Degradation of Chondrocytes Through ALKBH5-dependent Runx2 M6a Modification in the Pathogenesis of Osteoarthritis

Disruption of glucocorticoid signalling in osteoblasts attenuates age-related surgically induced osteoarthritis.

Runx2 deletion in hypertrophic chondrocytes impairs osteoclast mediated bone resorption

Deletion of Runx1 in osteoclasts impairs murine fracture healing through progressive woven bone loss and delayed cartilage remodeling

Runx1 alleviates osteoarthritis progression in aging mice

Runx1 protects against the pathological progression of osteoarthritis

Deletion of the Transforming Growth Factor Β Receptor Type II Gene in Articular Chondrocytes Leads to a Progressive Osteoarthritis-Like Phenotype in Mice.

Early Subchondral Bone Changes in an Osteoarthritis Model in Wild Type and Tgf-Alpha Knockout Mice

Conditional Deletion of Fgfr3 in Chondrocytes leads to Osteoarthritis-like Defects in Temporomandibular Joint of Adult Mice

Cdc42 is Essential for Both Articular Cartilage Degeneration and Subchondral Bone Deterioration in Experimental Osteoarthritis

Deletion of DYRK1A Accelerates Osteoarthritis Progression Through Suppression of EGFR-ERK Signaling

Reduced Egfr Signaling Enhances Cartilage Destruction in A Mouse Osteoarthritis Model

Notch Signaling Regulates MMP-13 Expression Via Runx2 in Chondrocytes.